Jamjoom Pharma announces foreign BOD member resignation and appointment of another

Jamjoom Pharmaceuticals Factory Company announced that the Board of Directors issued a decision by accepting the resignation of Simon Goeller from his position as a Board member (Independent) on the 3rd of July 2023 due to taking a new position of employment with another company.

He anticipates that this may create a perceived conflict of interest in his Board membership. BOD also approved appointing Georges P. Schorderet as a Board member (Independent) from the 4th of July 2023 until the end of the current Board’s term.

Georges is a Swiss National executive acting as a Board member in several companies based in Saudi Arabia and Switzerland.

Georges held various C-level roles at Almarai Company in Riyadh, Saudi Arabia between 2004 and 2019 and was the CEO of Almarai between 2015 and 2019. Prior to this, Georges was the Chief Financial Officer of Swissair Group from 1995 to 2001.

Georges holds an MBA from International Management Institute, Switzerland along with various other Certifications from reputable global institutions.

The company said that the board Approval May not be Deemed Final, this Appointment Shall Be Put before the First General Assembly Meeting for Approval.